In that 2023 announcement, they were highlighting the fact that it would be the first approved treatment for children under 12. But the application was for children up to 18 years.
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-71
-
- There are more pages in this discussion • 314 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
0.000(0.00%) |
Mkt cap ! $1.461B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 8992 | $1.34 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.05 | 391 | 1 |
View Market Depth
| Last trade - 09.51am 05/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
Day chart unavailable